cerrar
Tagged with Novartis

China’s Pharma Talent Strategy
Given the undeniably challenging and dynamic China market, most industry stakeholders would agree that the paramount factor behind the success of…

Sumalee Kristarnin – Country President, Novartis Thailand
Sumalee Kristarnin, country president of Novartis Thailand, shares the main initiatives of the affiliate in Thailand to take care of people, employees…

Cell & Gene Therapies: Transforming our Vision of Healthcare…
Emanuele Ostuni, head of cell & gene therapy for Novartis Oncology in Europe, outlines how stakeholders across the biopharmaceutical value chain…

Chris Lu – CEO, Laekna Therapeutics, China
Dr. Chris Lu, CEO and cofounder of Laekna Therapeutics, shares Laekna’s ambition to deliver cures and improve the quality of life of patients…

US Medicare Vows to Increase Payments for Cell & Gene…
Medicare, a national health insurance program in the United States covering Americans aged 65 and older as well as younger people with disabilities,…

Top 20 Pharma Companies in Sweden 2018
The Top 20 pharma companies in Sweden ranked by sales in 2018. Out in front is Swiss giant Novartis with approx USD 256 million in sales, followed by…

Ingrid Zhang – President, Novartis Pharmaceuticals China
Ingrid Zhang, president of Novartis Pharmaceuticals China, shares the transformation of Novartis China in the past two years in line with the global…

Basyouni Abuseif – Country President and CPO Head, Novartis…
Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the…

Sandoz: CEO Quits, Spinoff Rumours Swirl
Richard Francis, CEO of Sandoz will step down at the end of the March. The abrupt announcement will fan the flames of rumours that parent company…

Top 10 Global Orphan Drug Companies Ranking 2017
The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants Novartis and Roche take the top two…

Denis Delval – CEO, LFB, France
Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the new LFB.   My vision is that…

‘Reimagined’ Novartis Grows 5% in 2018
Basel-headquartered pharma giant Novartis announced its financial results for 2018 this week, showcasing full year net sales growth of five percent…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here